Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
6.85
+0.09 (1.33%)
At close: Mar 6, 2026, 4:00 PM EST
6.86
+0.01 (0.15%)
After-hours: Mar 6, 2026, 7:53 PM EST
Lexeo Therapeutics Market Cap
Lexeo Therapeutics has a market cap or net worth of $499.96 million as of March 6, 2026. Its market cap has increased by 275.06% in one year.
Market Cap
499.96M
Enterprise Value
385.66M
1-Year Change
275.06%
Ranking
Category
Stock Price
$6.85
Market Cap Chart
Since the IPO on November 3, 2023, Lexeo Therapeutics's market cap has increased from $271.36M to $499.96M, an increase of 84.25%. That is a compound annual growth rate of 29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 499.96M | -31.02% |
| Dec 31, 2025 | 724.76M | 232.99% |
| Dec 31, 2024 | 217.65M | -39.13% |
| Dec 29, 2023 | 357.58M | 31.78% |
| Nov 3, 2023 | 271.36M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neumora Therapeutics | 509.82M |
| Prothena Corporation | 509.26M |
| Contineum Therapeutics | 504.47M |
| Rocket Pharmaceuticals | 503.76M |
| CorMedix | 498.02M |
| Zevra Therapeutics | 494.86M |
| Invivyd | 490.66M |
| Tenax Therapeutics | 480.35M |